SB-275833 ointment, 1%

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

ImpetigoSkin Infections, Bacterial

Phase 3

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

CompletedNCT00133874

GlaxoSmithKlineSkin Infections, Bacterial

Start: 2005-04-30End: 2005-09-30Updated: 2017-01-23

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

CompletedNCT00133848

GlaxoSmithKlineImpetigo

Start: 2005-04-30End: 2006-01-31Target: 210Updated: 2016-09-23